Study reveals new survival strategy for bacteria exposed to antibiotics

Findings may aid the design of antibacterial therapies

2013-01-04

(Press-News.org) Researchers have uncovered a new way that some bacteria survive when under siege by antibiotics.

This survival mechanism is fundamentally different from other, known bacterial strategies. Understanding it may be useful for designing drugs that target hard-to-treat bacterial strains, such as drug-resistant tuberculosis, an increasingly urgent public health problem. The study is based on Mycobacterium smegmatis, a cousin of the microbe that causes TB, and its response to the TB drug isoniazid.

The research, by Yuichi Wakamoto of the University of Tokyo and Neeraj Dhar of the Swiss Federal Institute of Technology in Lausanne and colleagues, appears in the 4 January issue of Science. The journal is published by AAAS, the nonprofit, international science society.

Researchers observed as early as 1944 that antibiotics are less effective against cell populations that aren't proliferating. More recently, experiments have shown that some bacteria survive exposure to antibiotics thanks to a population of non-dividing "persister cells" that are present in the population even before the antibiotic treatment begins.

"This concept has been widely accepted as a general explanation for bacterial persistence despite very limited experimental support," said Wakamoto.

Wakamoto and colleagues now report that non-dividing persister cells are not responsible for the survival of M. smegmatis exposed to isoniazid. In fact, cell survival is not related to growth rate at all. Instead, random pulses of a bacterial enzyme called KatG make it possible for some cells to survive antibiotic treatment.

"Our Science paper provides clear experimental proof that other mechanisms of persistence also exist," said Dhar. "Our findings necessitate the re-examination of the mechanisms of persistence at the single-cell level in other bacteria, including Mycobacterium tuberculosis, which causes TB in humans."

The researchers studied single M. smegmatis cells in microfluidic cultures, treated with isoniazid. This drug is a "pro-drug" that does not become active until it is administered and interacts with certain compounds in the cell. In the case of M. smegmatis, it's KatG that activates isoniazid.

Individual cells' fates were not correlated with their growth rates but rather with their production of KatG. Each cell produced KatG in random pulses that determined the cell's chances of survival.

The researchers conclude that in certain cells, there were periods in between pulses when enzyme conversion of the pro-drug was barely possible. Thus a few cells probably avoided being killed by the activated antibiotic.

"At present we can only speculate as to whether the same or similar mechanisms exist in other bacterial species, although we think this is likely," said Wakamoto.

###This research was supported by the Charles H. Revson Foundation, the Heiser Program for Research in Leprosy and Tuberculosis of the New York Community Trust, the Harvey L. Karp Discovery Fellowship and the JST PRESTO Program, the Bill and Melinda Gates Foundation, the National Institutes of Health, and the Swiss National Science Foundation.

The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society and publisher of the journal Science (www.sciencemag.org) as well as Science Translational Medicine (www.sciencetranslationalmedicine.org) and Science Signaling (www.sciencesignaling.org). AAAS was founded in 1848 and includes some 261 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of 1 million. The non-profit AAAS (www.aaas.org) is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy, international programs, science education, public engagement, and more. For the latest research news, log onto EurekAlert!, www.eurekalert.org, the premier science-news Web site, a service of AAAS. See www.aaas.org.

ELSE PRESS RELEASES FROM THIS DATE:

Steroids that only nature could make on a large scale -- Until now

2013-01-04

LA JOLLA, CA – January 3, 2013 – Scientists at The Scripps Research Institute (TSRI) have achieved a feat in synthetic chemistry by inventing a scalable method to make complex natural compounds known as "polyhydroxylated steroids." These compounds, used in heart-failure medications and other drugs, have been notoriously problematic to synthesize in the laboratory. The researchers demonstrated the new strategy by synthesizing ouabagenin [wa-bah-jenn-in], a close chemical cousin of ouabain, which Somali tribes once used as a potent poison on the tips of their arrows but ...

Coral records suggest that recent El Nino activity rises above noisy background

2013-01-04

VIDEO: By studying a set of fossil corals that are as much as 7,000 years old, scientists have dramatically expanded the amount of information available on the El Nino-Southern Oscillation, a... Click here for more information. By examining a set of fossil corals that are as much as 7,000 years old, scientists have dramatically expanded the amount of information available on the El Nino-Southern Oscillation, a Pacific Ocean climate cycle that affects climate worldwide. The ...

Rethinking bacterial persistence

2013-01-04

It's often difficult to completely eliminate a bacterial infection with antibiotics; part of the population usually manages to survive. We've known about this phenomenon for quite some time, dating back nearly to the discovery of penicillin. For more than 50 years, scientists have believed that the resistant bacteria were individuals that had stopped growing and dividing. Up to now, in fact, it hasn't been possible to track the growth of cells before and after their exposure to antibiotics, which makes any analysis of the phenomenon quite imprecise. "Using microfluidics, ...

First meteorite linked to Martian crust

2013-01-04

Washington, D.C.—After extensive analyses by a team of scientists led by Carl Agee at the University of New Mexico, researchers have identified a new class of Martian meteorite that likely originated from the Mars's crust. It is also the only meteoritic sample dated to 2.1 billion years ago, the early era of the most recent geologic epoch on Mars, an epoch called the Amazonian. The meteorite was found to contain an order of magnitude more water than any other Martian meteorite. Researchers from the Carnegie Institution (Andrew Steele, Marilyn Fogel, Roxane Bowden, and Mihaela ...

Bering Sea study finds prey density more important to predators than biomass

2013-01-04

CORVALLIS, Ore. – Marine resource managers often gauge the health of species based on overall biomass, but a new study of predator-prey relationships in the Bering Sea found that it isn't the total number of individuals that predators care about – it's how densely they are aggregated. It's more than searching for an easy meal, the researchers say. Predators need to balance how much energy they expend in searching for food with the caloric and nutrient value of that which they consume. When prey doesn't aggregate, however, the search for food becomes much more difficult ...

Researchers: Online science news needs careful study

2013-01-04

MADISON — A science-inclined audience and wide array of communications tools make the Internet an excellent opportunity for scientists hoping to share their research with the world. But that opportunity is fraught with unintended consequences, according to a pair of University of Wisconsin–Madison life sciences communication professors. Dominique Brossard and Dietram Scheufele, writing in a Perspectives piece for the journal Science, encourage scientists to join an effort to make sure the public receives full, accurate and unbiased information on science and technology. "This ...

Mayo Clinic researchers find new molecule to target in pancreatic cancer treatment

2013-01-04

JACKSONVILLE, Fla. — Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often lethal cancer is resistant to conventional chemotherapy. The findings are published in the Jan. 3 online issue of PLOS ONE. The researchers decoded a molecular pathway that is switched "on" at all times, promoting accelerated growth of pancreatic tumors, and that discovery revealed ways to disable the pathway. They say one strategy ...

Editing the genome with high precision

2013-01-04

CAMBRIDGE, MA -- Researchers at MIT, the Broad Institute and Rockefeller University have developed a new technique for precisely altering the genomes of living cells by adding or deleting genes. The researchers say the technology could offer an easy-to-use, less-expensive way to engineer organisms that produce biofuels; to design animal models to study human disease; and to develop new therapies, among other potential applications. To create their new genome-editing technique, the researchers modified a set of bacterial proteins that normally defend against viral invaders. ...

An embryo that is neither male nor female

2013-01-04

So, is it a girl or a boy? This is the first question parents ask at the birth of an infant. Though the answer is obvious, the mechanism of sex determination is much less so. Researchers at the University of Geneva (UNIGE) attempt to shed light on this complex process by identifying the crucial role played by insulin and IGF1 and IGF2 growth factors, a family of hormones known for its role in metabolism and growth. In the absence of these factors at the time of sex determination, embryos do not differentiate into either male or female and have no adrenal glands. The results ...

Turning smartphones into secure and versatile keys

2013-01-04

Smartphones and tablets have become an integral part of our daily lives. The capabilities of these handily sized mini-computers seem almost boundless as we phone friends, shoot holiday snaps, lose ourselves in a new music download or access the internet to obtain the boarding card for our next fl ight in comfort. Does it not seem logical, then, that we should make use of these constant companions as the key to our cars, front doors or lockers as well? A few such solutions are already available, but what's still missing is widespread market acceptance. At this year's CeBIT ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC